The Integrative Studies on the Functional A-to-I RNA Editing Events in Human Cancers

Area of Science:

• Genomics
• Molecular Biology
• Cancer Research

Background:

• Adenosine-to-inosine (A-to-I) RNA editing is prevalent in humans, implicated in cancer development.
• A comprehensive understanding of functional A-to-I RNA editing in cancers remains limited.

Purpose of the Study:

• To systematically analyze the tumorigenic mechanisms of A-to-I RNA editing events across diverse cancer types.
• To create a comprehensive map of functional A-to-I RNA editing events in cancer.

Main Methods:

• Analysis of A-to-I RNA editing events in samples from The Cancer Genome Atlas across 33 cancer types.
• Systematic functional annotation of approximately 1,500,000 quantified RNA editing events.
• Identification of potentially functional events based on editing frequencies and predicted impacts.

Main Results:

• Identification of 24,236 potentially functional A-to-I RNA editing events across 33 cancer types.
• Examples of identified events include those in APOL1, IGFBP3, GRIA2, BLCAP, and miR-589-3p.
• These events show potential roles in tumorigenesis through altered gene expression, protein function, splicing, and microRNA regulation.

Conclusions:

• The identified functional A-to-I RNA editing events offer crucial insights into cancer pathology.
• This resource aids in understanding the role of RNA editing in tumorigenesis.
• The findings provide a foundation for further research into A-to-I editing as a cancer biomarker or therapeutic target.